Harvard Medicine News
One Year In: Therapeutics

Vaccines were developed in record time, but COVID-19 treatments are lagging. MassCPR therapeutics leaders weigh in on why.
photo of shelves stocked with prescription drugs at a pharmacy
AI and Alzheimer's Disease

Can artificial intelligence speed the search for new Alzheimer’s disease treatments?
Stylized representation of phosphorylation of tau proteins
Safety Check

New data reveal the risk of allergic reactions after COVID-19 mRNA vaccinations.
Two vaccine vials, one with a syringe in it
Concussion Consequences

Researchers are learning more about the links between concussions and serious long-term health effects.
silhouette of a man alone sitting on bed looking out window
EXTRAS
Health Equity, COVID-19 Webinar
Register: Rear Adm. Felicia Collins speaks
HMS Responds to Coronavirus
Insights from HMS physicians, scientists
Subscribe | Contact Us | Unsubscribe
Harvard Medical School
Published by Harvard Medical School, Office of Communications and External Relations
© 2025 The President and Fellows of Harvard College